Select Medical Holdings Corporation (SEM): Boston Consulting Group Matrix [10-2024 Updated]
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Select Medical Holdings Corporation (SEM) Bundle
In the ever-evolving landscape of healthcare, Select Medical Holdings Corporation (SEM) stands out with its diverse service offerings and financial performance as of 2024. Utilizing the Boston Consulting Group Matrix, we can categorize SEM's business segments into Stars, Cash Cows, Dogs, and Question Marks. This analysis reveals the strengths and weaknesses within its portfolio, highlighting key revenue growth, profitability, and areas needing strategic reevaluation. Dive deeper to explore how SEM is navigating its market challenges and opportunities.
Background of Select Medical Holdings Corporation (SEM)
Select Medical Holdings Corporation, incorporated in 1997, is a prominent operator of various healthcare facilities across the United States. As of September 30, 2024, the company operates in 46 states and the District of Columbia, managing a diverse portfolio that includes:
- 106 critical illness recovery hospitals in 29 states
- 34 rehabilitation hospitals in 13 states
- 1,925 outpatient rehabilitation clinics in 39 states
- 549 occupational health centers in 41 states
- 156 onsite clinics at employer worksites
The company's operations are segmented into four key areas: critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and the Concentra segment. For the nine months ending September 30, 2024, Select Medical reported total revenue of approximately $5.31 billion, with contributions from each segment as follows:
- 35% from critical illness recovery hospitals
- 15% from rehabilitation hospitals
- 18% from outpatient rehabilitation clinics
- 27% from the Concentra segment
The critical illness recovery hospital segment focuses on patients with complex medical needs who are recovering from critical illnesses, while the rehabilitation segment provides intensive physical rehabilitation care. The outpatient rehabilitation segment offers physical, occupational, and speech rehabilitation services. The Concentra segment specializes in occupational health services, including workers’ compensation injury care and physical therapy.
On July 26, 2024, Select Medical completed the initial public offering (IPO) of its subsidiary, Concentra Group Holdings Parent, raising approximately $499.7 million. Post-IPO, Select Medical retained an 81.74% ownership stake in Concentra, which continues to be consolidated in its financial results. This strategic move is part of Select Medical's ongoing efforts to enhance operational efficiency and shareholder value.
Select Medical Holdings Corporation (SEM) - BCG Matrix: Stars
Rehabilitation Hospital Segment
The Rehabilitation Hospital segment shows strong growth with a 14.4% revenue increase in Q3 2024, reaching $282.7 million compared to $247.1 million in Q3 2023. This growth is primarily driven by a 6.1% increase in revenue per patient day, which rose to $2,148 from $2,025. The number of patient days increased by 4.2% to 116,835 days in Q3 2024 from 112,095 days in Q3 2023, with an occupancy rate of 82% in Q3 2024.
Critical Illness Recovery Hospital Segment
The Critical Illness Recovery Hospital segment also reported positive results, with revenue rising by 3.4% to $583.0 million in Q3 2024 from $563.6 million in Q3 2023. Revenue per patient day increased by 2.4% to $2,145, and patient days increased by 1.1% to 270,760 days. The occupancy rate for this segment was 65% in Q3 2024.
Outpatient Rehabilitation Segment
In the Outpatient Rehabilitation segment, revenue increased by 6.9% year-over-year to $312.0 million in Q3 2024, up from $291.8 million in Q3 2023. This growth is attributed to a 5.6% increase in patient visits, totaling 2,773,465 visits in Q3 2024, compared to 2,627,362 visits in Q3 2023. The revenue per visit increased by 1.0% to $101.
Concentra Segment
Concentra's revenue grew by 3.3% in Q3 2024, reaching $489.6 million compared to $474.0 million in Q3 2023. The increase was driven by a 3.7% rise in revenue per visit to $141, with a total of 3,258,605 visits in Q3 2024, down slightly from 3,281,042 visits in Q3 2023.
Adjusted EBITDA Performance
Adjusted EBITDA for the Critical Illness Recovery Hospital segment increased by 26.5% year-to-date, indicating a strong operational performance. The overall company revenue reached $1.76 billion in Q3 2024, marking a 5.7% increase compared to the previous year.
| Segment | Q3 2024 Revenue | Q3 2023 Revenue | Revenue Growth (%) | Revenue per Patient Day | Patient Days | Occupancy Rate (%) |
|---|---|---|---|---|---|---|
| Rehabilitation Hospital | $282.7 million | $247.1 million | 14.4% | $2,148 | 116,835 | 82% |
| Critical Illness Recovery Hospital | $583.0 million | $563.6 million | 3.4% | $2,145 | 270,760 | 65% |
| Outpatient Rehabilitation | $312.0 million | $291.8 million | 6.9% | $101 | 2,773,465 | N/A |
| Concentra | $489.6 million | $474.0 million | 3.3% | $141 | 3,258,605 | N/A |
| Total Company Revenue | $1.76 billion | $1.67 billion | 5.7% | N/A | N/A | N/A |
Select Medical Holdings Corporation (SEM) - BCG Matrix: Cash Cows
Rehabilitation Hospital Segment
The Rehabilitation Hospital segment maintains strong EBITDA margins of approximately 21.3%. Revenue increased 13.5% to $816.2 million for the nine months ended September 30, 2024, compared to $719.4 million for the same period in 2023. Patient days increased 6.2% to 350,724 days, with revenue per patient day rising 5.9% to $2,119.
Concentra Segment
Concentra consistently generates significant cash flow, contributing to overall profitability. Revenue increased 2.7% to $1.435 billion for the nine months ended September 30, 2024, compared to $1.397 billion for the same period in 2023. The revenue per visit increased 3.7% to $140, with patient visits totaling 9,628,515.
Total Stockholders’ Equity
Total stockholders’ equity increased to $1.91 billion by Q3 2024, a strong indicator of financial health. This increase reflects a robust balance sheet that supports ongoing operational needs and growth strategies.
Cash Dividends
Cash dividends declared for common stockholders show a stable return on investment, with dividends of $0.125 per share being paid out, totaling approximately $48.5 million for the nine months ended September 30, 2024.
Net Income Trend
The company has maintained a positive net income trend, reaching $96.9 million in Q3 2024, compared to $60.8 million in Q3 2023, indicating a growth of 59.3%.
| Segment | Revenue (Q3 2024) | EBITDA Margin | Net Income (Q3 2024) |
|---|---|---|---|
| Rehabilitation Hospital | $282.7 million | 21.3% | $53.3 million |
| Concentra | $489.6 million | 20.9% | $86.2 million |
| Outpatient Rehabilitation | $312.0 million | 8.8% | $19.2 million |
| Total | $1.761 billion | 13.1% | $141.1 million |
Overall, these segments contribute significantly to Select Medical Holdings Corporation's cash flow, positioning them as key cash cows in the company's portfolio.
Select Medical Holdings Corporation (SEM) - BCG Matrix: Dogs
Outpatient Rehabilitation Segment
The outpatient rehabilitation segment experienced a decline in adjusted EBITDA by 8.3% year-to-date, with adjusted EBITDA reported at $82.0 million for the nine months ended September 30, 2024, compared to $89.4 million for the same period in 2023. The adjusted EBITDA margin decreased to 8.8% from 10.0% in the previous year.
Other Segment
The other segment reported losses, indicating a lack of profitability and potential operational inefficiencies, with a loss from operations of ($51.3 million) for the three months ended September 30, 2024, compared to a loss of ($44.9 million) for the same period in 2023.
Operational Costs
High operational costs in the other segment led to a negative adjusted EBITDA of ($35.3 million) for the three months ended September 30, 2024. This indicates significant financial strain on resources without corresponding returns.
Growth Prospects
Limited growth prospects in underperforming segments could drain resources. The overall revenue for the other segment was $93.9 million for the three months ended September 30, 2024, reflecting a 5.3% increase compared to $89.2 million for the same period in 2023; however, this growth is overshadowed by the operational losses.
| Segment | Adjusted EBITDA (9 Months 2024) | Adjusted EBITDA Margin (9 Months 2024) | Loss from Operations (3 Months 2024) | Revenue (3 Months 2024) |
|---|---|---|---|---|
| Outpatient Rehabilitation | $82.0 million | 8.8% | $19.2 million | $312.0 million |
| Other | ($35.3 million) | N/A | ($51.3 million) | $93.9 million |
Select Medical Holdings Corporation (SEM) - BCG Matrix: Question Marks
Future growth of the Outpatient rehabilitation segment is uncertain despite revenue increase.
For the three months ended September 30, 2024, the Outpatient Rehabilitation segment generated revenue of $312.0 million, reflecting a 6.9% increase from $291.8 million in the same period of 2023. However, patient visits only increased by 5.6% to 2,773,465 visits, indicating potential challenges in sustaining growth in a competitive market.
Critical illness recovery hospital faces growing competition, impacting market share.
The Critical Illness Recovery Hospital segment reported revenue of $582.9 million for Q3 2024, a 3.4% increase from $563.6 million in Q3 2023. However, the occupancy rate remained at 65%, and the segment's income from operations grew modestly to $33.7 million, suggesting that competition is affecting its market share.
Concentra's performance may fluctuate due to regulatory changes and market dynamics.
The Concentra segment's revenue increased by 3.3% to $489.6 million for the three months ended September 30, 2024. Nonetheless, its Adjusted EBITDA margin declined to 20.7% from 20.9%, highlighting potential vulnerability to regulatory changes and market fluctuations.
The Other segment's restructuring needs assessment to determine its viability.
The Other segment reported a revenue increase of 5.3% to $93.9 million for Q3 2024. However, its income from operations was a loss of $51.3 million, necessitating a thorough assessment of its restructuring efforts to evaluate future viability.
Potential for expansion in new markets, but requires strategic investment and risk management.
While Select Medical Holdings has opportunities for expansion into new markets, this requires significant strategic investment. The company reported a total revenue of $1,761.2 million for Q3 2024, a 5.7% increase compared to $1,665.7 million in Q3 2023, indicating overall growth potential but also a need for effective risk management strategies.
| Segment | Q3 2024 Revenue (in millions) | Q3 2023 Revenue (in millions) | Revenue Growth (%) | Operating Income (in millions) | Occupancy Rate (%) |
|---|---|---|---|---|---|
| Outpatient Rehabilitation | $312.0 | $291.8 | 6.9% | N/A | N/A |
| Critical Illness Recovery Hospital | $582.9 | $563.6 | 3.4% | $33.7 | 65% |
| Concentra | $489.6 | $474.0 | 3.3% | $86.2 | N/A |
| Other | $93.9 | $89.2 | 5.3% | ($51.3) | N/A |
| Total | $1,761.2 | $1,665.7 | 5.7% | $141.1 | N/A |
In summary, Select Medical Holdings Corporation (SEM) presents a mixed portfolio through the lens of the Boston Consulting Group Matrix. The Stars in their business, particularly the rehabilitation hospital segment, are driving significant growth and profitability, while Cash Cows like Concentra provide a stable financial foundation. However, challenges remain in the Dogs category, especially with declining performance in the outpatient rehabilitation segment, and the Question Marks indicate uncertainty surrounding future growth and competition. As SEM navigates these dynamics, strategic focus and investment will be crucial to capitalize on opportunities while addressing underperforming areas.
Article updated on 8 Nov 2024
Resources:
- Select Medical Holdings Corporation (SEM) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Select Medical Holdings Corporation (SEM)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Select Medical Holdings Corporation (SEM)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.